Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998

Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002)

Published:2005-08 Issue:4 Volume:52 Page:323-329
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Hirakata Yoichi,Matsuda Junichi,Miyazaki Yoshitsugu,Kamihira Shimeru,Kawakami Sayoko,Miyazawa Yukihisa,Ono Yasuo,Nakazaki Nobuhiko,Hirata Yasuyoshi,Inoue Matsuhisa,Turnidge John D.,Bell Jan M.,Jones Ronald N.,Kohno Shigeru

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference19 articles.

1. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in southern and western Europe in 1997–1998;Babini;J. Antimicrob. Chemother.,2000

2. Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: Regional results from SENTRY Antimicrobial Surveillance Program (1998–99);Bell;Diagn. Microbiol. Infect. Dis.,2002

3. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat;Bradford;Clin. Microbiol. Rev.,2001

4. A functional classification scheme for β-lactamases and its correlation with molecular structure;Bush;Antimicrob. Agents Chemother.,1995

5. Bases of variation in resistance to β-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamase;Gheorghiu;J. Antimicrob. Chemother.,1997

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial diversity in Buruli ulcer lesions in Ghana;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-08

2. Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa;Antimicrobial Resistance & Infection Control;2023-04-04

3. Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018);Infection and Drug Resistance;2022-11

4. Genetic diversity and multidrug resistance of phylogenic groups B2 and D in InPEC and ExPEC isolated from chickens in Central China;BMC Microbiology;2022-02-18

5. Distribution and association of antimicrobial resistance and virulence traits in Escherichia coli isolates from healthy waterfowls in Hainan, China;Ecotoxicology and Environmental Safety;2021-09